rs143365662
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000055682.12(NEXMIF):āc.3753A>Gā(p.Ile1251Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000363 in 1,210,463 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000055682.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.3753A>G | p.Ile1251Met | missense_variant | 3/4 | ENST00000055682.12 | NP_001008537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.3753A>G | p.Ile1251Met | missense_variant | 3/4 | 1 | NM_001008537.3 | ENSP00000055682 | P1 | |
NEXMIF | ENST00000616200.2 | c.3753A>G | p.Ile1251Met | missense_variant | 3/5 | 1 | ENSP00000480284 | P1 | ||
NEXMIF | ENST00000642681.2 | c.3753A>G | p.Ile1251Met | missense_variant | 3/3 | ENSP00000495800 |
Frequencies
GnomAD3 genomes AF: 0.000115 AC: 13AN: 112613Hom.: 0 Cov.: 22 AF XY: 0.0000862 AC XY: 3AN XY: 34783
GnomAD3 exomes AF: 0.0000712 AC: 13AN: 182631Hom.: 0 AF XY: 0.0000743 AC XY: 5AN XY: 67251
GnomAD4 exome AF: 0.0000282 AC: 31AN: 1097850Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 14AN XY: 363234
GnomAD4 genome AF: 0.000115 AC: 13AN: 112613Hom.: 0 Cov.: 22 AF XY: 0.0000862 AC XY: 3AN XY: 34783
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 04, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at